Investor News 2002

December 20, 2002
Bayer reaches agreement with U.S. authorities
Download PDF collect (59 KB)
December 16, 2002
FDA Approves Once-Daily Cipro XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs)
Download PDF collect (122 KB)
December 6, 2002
Plans for the future of Pharmaceuticals have the support of the Supervisory Board
Download PDF collect (94 KB)
December 5, 2002
Strategic options for Rhein Chemie under review
Download PDF collect (26 KB)
December 5, 2002
New rules for Corporate Governance
Download PDF collect (27 KB)
December 2, 2002
Bayer and GlaxoSmithKline: Two New Studies on Erectile Dysfunction Presented
Download PDF collect (30 KB)
November 29, 2002
Acarbose - Findings of the first large-scale study
Download PDF collect (65 KB)
November 22, 2002
Vardenafil Receives Positive Opinion from European Committee for Proprietary Medicinal Products
Download PDF collect (68 KB)
November 13, 2002
Bayer CropScience to sell additional products to Makhteshim-Agan
Download PDF collect (67 KB)
November 12, 2002
Q3 2002 Statement
Download PDF collect (685 KB)
November 11, 2002
Bayer sells household insecticides for EUR 725 million to SC Johnson
Download PDF collect (64 KB)
October 30, 2002
Bayer Submits Additional New Drug Application For Once-Daily Cipro XR in U.S.
Download PDF collect (62 KB)
October 28, 2002
Rolf Classon Appointed Chairman of the Board of Management of Bayer HealthCare AG
Download PDF collect (58 KB)
October 28, 2002
Bayer CropScience AG to sell a range of products to BASF
Download PDF collect (66 KB)
October 28, 2002
Bayer's Cipro Patent Affirmed by U.S. Courts
Download PDF collect (63 KB)
October 16, 2002
Bayer and SC Johnson have signed Letter of Intent
Download PDF collect (59 KB)
October 4, 2002
Bayer plans to sell Rhein Chemie to Advent International
Download PDF collect (67 KB)
October 2, 2002
Bayer CropScience agrees to products divestments to Makhteshim-Agan
Download PDF collect (62 KB)
October 1, 2002
Approval of 200 liter fermenters for Kogenate increases production capacity for the U.S.
Download PDF collect (67 KB)
October 1, 2002
Bayer CropScience becomes first legally independent subgroup
Download PDF collect (58 KB)

October 1, 2002
Study Comparing Once-Daily Cipro XR to Conventional Twice-Daily Cipro

Download PDF collect (86 KB)
September 23, 2002
ISSIR Congress: New Vardenafil Data
Download PDF collect (90 KB)
September 18, 2002
Bayer CropScience agrees to sell wheat herbicide to Arvesta Corporation
Download PDF collect (65 KB)
September 12, 2002
Bayer cuts a further 4,700 jobs worldwide
Download PDF collect (66 KB)
August 27, 2002
New Immune Globulin Intravenous Treatment for Approval in Key Global Markets Submitted
Download PDF collect (63 KB)
August 15, 2002
Pharmaceuticals Division signs declaration of intent to market telmisartan
Download PDF collect (66 KB)
August 01, 2002
Stockholder's Newsletter 2002: Interim Report for the First Half
Download PDF collect (582 KB)
July 24, 2002
Bayer agrees to acquire Visible Genetics Inc. for US$ 61.4 million
Download PDF collect (72 KB)
July 24, 2002
FDA approvable letter for Vardenafil
Download PDF collect (72 KB)
July 17, 2002
Bayer plans to sell Haarmann & Reimer to EQT
Download PDF collect (83 KB)
June 03, 2002
Bayer CropScience ready for launch
Download PDF collect (72 KB)
May 31, 2002
Bayer to keep fibers business
Download PDF collect (58 KB)
May 31, 2002
FTC gives the green light for Bayer to acquire Aventis CropScience
Download PDF collect (66 KB)
May 30, 2002
Bayer sells stake in Agfa-Gevaert
Download PDF collect (11 KB)
May 22, 2002
Bayer taking additional steps to realign cost base of Pharmaceutical Business
Download PDF collect (84 KB)

May 21, 2002
New BAY 43-9006 Phase I data presented at 2002 ASCO meeting

Download PDF collect (111 KB)
May 13, 2002
New EUR 170 million TDA plant
Download PDF collect (12 KB)
May 02, 2002
Avalox i.v. approved in Germany: noticeable drop in treatment costs possible
Download PDF collect (77 KB)
April 26, 2002
Information for Stockholders 2002: Interim Report for the First Quarter
Download PDF collect (171 KB)

April 25, 2002
Moxifloxacin IV Reduces Healthcare Costs and Provides Excellent Outcome for Patients hospitalized with Community-Acquired Pneumonia

Download PDF collect (74 KB)
April 17, 2002
Bayer divests generics business in Spain
Download PDF collect (69 KB)
April 17, 2002
European Commission clears planned transaction:Bayer can acquire Aventis CropScience
Download PDF collect (12 KB)
April 15, 2002
New Bayer management team now complete
Download PDF collect (90 KB)
April 04, 2002
Bayer Pharma France sells generics business to Teva
Download PDF collect (9 KB)
March 25, 2002
Bayer's euro bonds a resounding success
Download PDF collect (83 KB)
March 13, 2002
Bayer expects much higher net income in 2002
Download PDF collect (239 KB)
March 12, 2002
Bayer plans to divest household insecticides
Download PDF collect (83 KB)

March 08, 2002
Bayer Corporation Submits New Drug Application for Once-Daily Formulation of Ciprofloxacin HCI and Ciprofloxacin

Download PDF collect (132 KB)
March 07, 2002
Klaus Kühn and Dr. Richard Pott appointed to the Bayer Management Board
Download PDF collect (16 KB)
March 07, 2002
Bayer to pay dividend of EUR 0.90 per share
Download PDF collect (10 KB)
March 06, 2002
Active ingredient in Aspirin reduces the risk of myocardial infarction and stroke
Download PDF collect (13 KB)
February 26, 2002
Patients Reported Vardenafil Significantly Improved Erectile Function Following Radical Prostatectomy
Download PDF collect (76 KB)
February 20, 2002
Bayer and Aventis Sign Letter of Intent on Joint Venture of Blood Plasma Business
Download PDF collect (13 KB)
February 05, 2002
Bayer receives offer for generics business in France
Download PDF collect (50 KB)
January 31, 2002
Bayer and GlaxoSmithKline Announce: EMEA Acceptance of Regulatory Filing for Vardenafil
Download PDF collect (57 KB)
January 24, 2002
Bayer stock makes its debut on the New York Stock Exchange
Download PDF collect (12 KB)
January 22, 2002
"New" Bayer Group will be more flexible to boost competitiveness and performance
Download PDF collect (20 KB)
January 11, 2002
Syngenta and Bayer reach agreement on patent disputes
Download PDF collect (10 KB)
January 09, 2002
Dr. Wolfgang Plischke appointed new General Manager of the Pharmaceuticals Business Group
Download PDF collect (9 KB)
January 09, 2002
Bayer and Burrill & Company form diagnostics capital fund
Download PDF collect (61 KB)

Services